Califf clears key hurdle to FDA top job
February 23, 2016Manufacturing and Production, Medical Communications, Research and Development
Dr Robert Califf, President Obama’s nominee to head up the US Food and Drugs Administration as commissioner, has edged a …
Europe approves Bayer haemophilia drug
February 22, 2016Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a
Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …
March edition of Pharmafocus live
February 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The March 2016 edition of Pharmafocus is now live and available to read here.
Amgen and UCB announce positive romosozumab results
February 22, 2016Medical Communications, Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, osteoporosis
Romosozumab development partners Amgen and UCB have announced positive top-line results from a Phase III study of the drug in postmenopausal …
Merck launches infertility programme in Uganda
February 22, 2016Medical Communications, Sales and Marketing Merck Serono
Germany’s Merck has extended its infertility programme ‘Merck More than a Mother’ to Uganda, launching the campaign in a second …
FDA to decide on Sanofi diabetes combo
February 22, 2016Research and Development, Sales and Marketing Lantus, Sanofi
Sanofi will be looking to August for a decision on its new type 2 diabetes combo LixiLan (lixisenatide and Lantus), …
Novartis drug PKC412 gets Breakthrough designation for AML
February 19, 2016Medical Communications, Research and Development FDA, Novartis, acute myeloid leukaemia
Novartis’ PKC412 (midostaurin) has become the latest in a sequence of FDA Breakthrough Therapy designations awarded this week- bagging the …
More evidence required for Alexion’s Kanuma, says NICE
February 18, 2016Medical Communications, Research and Development Alexion, Kanuma, LAL-D, rare diseases
NICE says it needs additional trial data before it can recommend Alexion’s enzyme replacement therapy Kanuma (sebelipase alfa) for the …
Give GPs feedback on prescribing habits to reduce antibiotic use, says study
February 18, 2016Medical Communications, Research and Development antimicrobial resistance
A trial of more than 1,500 GP practices has shown that sending general practitioners (GPs) letters giving feedback on their …
FDA approves Gilead’s Harvoni in two new indications
February 18, 2016Research and Development Gilead Sciences, MSD, harvoni, hepatitis C
The hepatitis C treatment battle had its latest development yesterday, with the FDA awarding Gilead Science’s market-leading drug Harvoni (ledipasvir/sofosbuvir) …
AZ’s durvalumab awarded breakthrough status in bladder cancer
February 18, 2016Research and Development AstraZeneca, FDA, bladder cancer
AstraZeneca, and its biologics/R&D arm MedImmune, have won FDA Breakthrough Therapy status for their bladder cancer drug durvalumab (MEDI4736), which …
MPS appoints global marketing leader
February 17, 2016Manufacturing and Production
Multi Packaging Solutions International, a global leader in value-added print and packaging solutions for the branded consumer, healthcare and multi-media …
Pfizer pays $784m to settle Protonix overcharge claims
February 17, 2016Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix
US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
FDA gives Roche MS drug breakthrough status
February 17, 2016Research and Development Genentech, MS, Roche
Roche subsidiary Genentech has been awarded US Food and Drug Administration (FDA) Breakthrough Therapy Designation for its drug Ocrevus (ocrelizumab) …
AbbVie becomes Dementia Consortium’s latest pharma partner
February 16, 2016Manufacturing and Production, Research and Development
AbbVie has become the latest pharmaceutical company to join The Dementia Consortium- a £4 million global collaboration aiming to speed …
What would BREXIT mean for pharma?
February 16, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development
It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
First Enbrel biosimilar launches in UK
February 16, 2016Manufacturing and Production, Research and Development Enbrel, Samsung Bioepis, eternacept, rheumatoid arthritis
Following its approval by the European Commission in January, Benepali has become the first biosimilar of Pfizer/Amgen’s Enbrel (etanercept) to …
Lilly suffers damaging Alimta patent blow
February 15, 2016Manufacturing and Production, Sales and Marketing Actavis, Alimta, Allergan, Eli Lilly, pemetrexed
Eli Lilly says it plans to appeal a UK High Court’s verdict that could imminently open its blockbuster lung cancer …
New 10-minute test will diagnose cancer at home
February 15, 2016Manufacturing and Production, Research and Development, Sales and Marketing Cancer
Scientists have developed a test for cancer that can diagnose the disease at home with the aid of just a …
FEC stats reveal pharma donations to presidential runners
February 12, 2016Sales and Marketing
Stats from the Center for Responsive Politics and the Federal Election Commission (FEC), have revealed the extent of donations from the …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
